Key statistics
On Monday, ReShape Lifesciences Inc (RSLS:NAQ) closed at 5.19, 12.82% above the 52 week low of 4.60 set on Oct 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.95 |
---|---|
High | 5.64 |
Low | 4.95 |
Bid | 4.95 |
Offer | 5.19 |
Previous close | 5.02 |
Average volume | 90.92k |
---|---|
Shares outstanding | 506.68k |
Free float | 461.52k |
P/E (TTM) | -- |
Market cap | 2.54m USD |
EPS (TTM) | -74.86 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 20:17 BST.
More ▼
Announcements
- ReShape Lifesciences Announces 1-for-58 Reverse Stock Split
- ReShape Lifesciences® Reports Second Quarter Ended June 30, 2024 Financial Results and Provides Corporate Update
- ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update
- ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
- ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update
- ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update
- ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update
- ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
- ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX
- ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX
More ▼